News and Press Releases
Closed Loop Medicine appoints Luba Greenwood as Chair of the Board of Directors
Appointment of notable investor and executive in healthcare and tech to support leadership team in preparation for commercial milestones 11 Sep 2024 -- London, UK -- Closed Loop Medicine Ltd.,...
Category: Biotechnology, Other, Pharmaceutical
Posted: September 11, 2024
Babraham Research Campus Cambridge CB22 3AT United Kingdom
COREX Logistics Appoints New CEO to Expand Global Growth
Clinical trial and pharmaceutical logistics specialists COREX Logistics have announced the appointment of Steve Healy as its new CEO of the organisation. Healy, COREX Logistics’ former Vice President of Business...
Category: Clinical Trials, Logistics, Other
Posted: July 30, 2024
Suite 40, The Guinness Enterprise Centre, Taylors Lane, Dublin 8, Ireland
Broken String Biosciences appoints Steve Becker as Chief Commercial Officer
Appointment brings extensive experience to lead commercial operations and accelerate growth in key global markets Cambridge, UK, 24 July 2024: Broken String Biosciences (“Broken String”), a genomics company driving development...
Category: BioManufacturing
Posted: July 24, 2024
Unit AB3-04, Level 3 BioData Innovation Centre Wellcome Genome Campus Hinxton Cambridge, CB10 1DR
Cherwell appoints new director of operations following retirement of Martyn Young
Newly appointed Andy Charteris to help company focus on continuous improvement initiatives 18 July 2024 -- Bicester, UK -- Cherwell, cleanroom microbiology solutions expert, is pleased to announce the appointment...
Category: BioManufacturing, Drug Discovery, Other, Pharmaceutical
Posted: July 18, 2024
Launton Business Centre Murdock Rd, Bicester OX26 4XB
Optibrium Appoints James Halle as chief commercial officer
Key appointment brings extensive software commercial experience to drive global growth 16 July 2024 – Cambridge, UK – Optibrium, a leading developer of software and AI solutions for drug discovery...
Category: Drug Discovery
Posted: July 16, 2024
Optibrium Ltd. 7221 Cambridge Research Park, Beach Drive, Cambridge, CB25 9TL, UK
Signant Health Appoints 20-Year Life Sciences Veteran Paul Richmond to executive leadership team as chief commercial officer
15 July 2024 – Pennsylvania, US – Signant Health, the leader in evidence generation for modern clinical trials, announced today the appointment of Paul Richmond as chief commercial officer. A...
Category: Clinical Trials, Other, Pharmaceutical
Posted: July 16, 2024
Mogrify appoints Dr Jonathan Appleby as chief scientific officer
Strategic hire bolsters executive leadership team as company progresses multiple therapeutic programmes toward and into clinical development 15 July 2024 – Cambridge, UK – Mogrify, a regenerative medicine company developing...
Category: Clinical Trials, Drug Discovery, Other, Pharmaceutical
Posted: July 15, 2024
Pascal Piedbois MD PhD joins One2Treat as chief medical officer to advance patient-centric innovation in clinical trial design and market access
One2Treat reflects patient priorities in a single multi-facet treatment assessment, reducing trial sample size and accelerating patient access to new treatments. 9 July 2024 -- Brussels, Belgium -- In this...
Category: Biotechnology, Clinical Trials, Other, Pharmaceutical
Posted: July 10, 2024
Clinigen appoints Fernando Ballester as Chief Financial Officer
2 July 2024 -- London, UK -- Clinigen, the global pharmaceutical services company, today announces the appointment of Fernando Ballester as chief financial officer (CFO), effective 1 August 2024. Fernando,...
Category: Other, Pharmaceutical
Posted: July 2, 2024
CN Bio appoints Lydia Seymour as VP People and Culture to further strengthen leadership team
Key appointment to support continued UK and US team expansion 27 June 2024 -- Cambridge, UK -- CN Bio, a leading provider of single- and multi-organ microphysiological systems, today announced...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 27, 2024
Avallano Strengthens Leadership with New Chief Strategy Officer to Drive AI-Powered Clinical Research Innovation
26 June 2024 -- South Carolina, US -- Avallano, an AI-enabled clinical research company, today announced the appointment of Michael A Ibara PharmD, as chief strategy officer (CSO). Dr Ibara...
Category: Clinical Trials, Drug Discovery, Pharmaceutical
Posted: June 26, 2024
X-Chem Strengthens Its Data-Driven Discovery Services
With new CBO appointment industry veteran Paul Davie joins X-Chem executive team to lead strategic growth and partnerships 20 June 2024 -- Massachusetts, US -- Small molecule drug discovery acceleration...
Category: Biotechnology, Drug Discovery, Pharmaceutical
Posted: June 20, 2024
Enterprise Therapeutics appoints Dr Renu Gupta as chief medical officer and Dr Janet Hammond as non-executive director
Appointments bring additional respiratory and late clinical-stage drug development experience as company commences Phase 2a clinical trial of its lead asset 17 June 2024, Brighton, UK -: Enterprise Therapeutics Ltd...
Category: Biotechnology, Pharmaceutical
Posted: June 17, 2024
Sussex Innovation Centre, University of Sussex, Science Park Square, Falmer, Brighton, BN1 9SB, UK
Formycon reports on the results of the annual general meeting
Management provides detailed report on financial year 2023 and current company performance. Shareholders approve all agenda items and formally approve the acts of the members of the management board and...
Category: BioManufacturing
Posted: June 13, 2024
Deep Genomics Expands Executive Leadership and Operations in Latest Strategic Growth Initiative
Company announces executive new hires and marks significant momentum with Cambridge, Massachusetts, US, site opening and Toronto, Canada, office expansion 13 June 2024 -- Massachusetts, US -- Deep Genomics, the...
Category: Biotechnology, Other, Pharmaceutical
Posted: June 13, 2024
480 University Ave, Suite 1300 Toronto, Ontario, Canada, M5G 1V2
